Julie Huang

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

Jeff P. Sharman, Steven Coutré, Richard R. Furman et al. · Journal of Clinical Oncology · 2019 · 215 citations · Full text

SPOP mutation leads to genomic instability in prostate cancer

Gunther Boysen, Christopher E. Barbieri, Davide Prandi et al. · eLife · 2015 · 192 citations · Full text

Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience

Warner Mampuya, David J. Frid, Michael Rocco et al. · American Heart Journal · 2013 · 173 citations · Full text

Drug Intolerance, Statin Intolerance, Cardiovascular Disease +4

Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

Francesca Demichelis, Sunita R. Setlur, Samprit Banerjee et al. · Proceedings of the National Academy of Sciences · 2012 · 52 citations · Full text

Gender Differences in Utilization of Effective Cardiovascular Secondary Prevention: A Cleveland Clinic Prevention Database Study

Leslie Cho, Byron J. Hoogwerf, Julie Huang et al. · Journal of Women s Health · 2008 · 50 citations · Full text